Photo: isbtweb.org
Mar 3, 2026, 14:21
Webinar on CAR-T Cells – Heterogeneity, Quality Control, and Adverse Events – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“ISBT Webinar: Let’s talk CAR-T cells – heterogeneity, quality control and adverse events.
4 March 2026 | 17:00–18:00 CET
Join Oulghazi Salim for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.
Ideal for scientists, transfusion professionals, MDs, and MSc/PhD students.
Register now and be part of the conversation”
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT
-
Oct 1, 2026, 23:45Martha Gulati: Oral MHT Is Associated With Increased Thrombotic Risk
-
Oct 1, 2026, 23:44Priya Sriskandarajah: HEMA-MED Trial Exploring Roginolisib Plus JAK Inhibitors in Myelofibrosis
-
Oct 1, 2026, 23:44Inge Vanhomwegen: Join Our Upcoming Webinar on D-dimer Testing
-
Oct 1, 2026, 23:43Bianca Rocca: Beyond API-CAT – Who Should Continue Anticoagulation, And for How Long?
-
Oct 1, 2026, 23:26Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
-
Oct 1, 2026, 23:16Ahmed Reda: New Ferritin Cutoffs For Iron Deficiency – Ash 2026